CUPR Share Price Performance
US$8.33
4.17 (100.60%)
Price US$8.33
Share PriceUS$8.33
CUPR Community Narratives
There are no narratives available yet.
Recent CUPR News & Updates
No updates
Cuprina Holdings (Cayman) Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.073
- Gross Margin
- -6.26%
- Net Profit Margin
- -3,229.52%
- Debt/Equity Ratio
- -131.0%
Cuprina Holdings (Cayman) Limited Competitors
About CUPR
- Founded
- 2019
- Employees
- 14
- CEO
- WebsiteView website
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.
Singaporean Market Performance
- 7 Days: 1.9%
- 3 Months: 11.0%
- 1 Year: 28.0%
- Year to Date: 13.2%
Over the last 7 days, the market has risen 1.9%, driven by gains of 2.1% in the Financials sector. As for the past 12 months, the market is up 28%. Earnings are forecast to grow by 7.3% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading